Pamela Ridley
Psychiatric/Mental Health · Rock Hill, SCNPI 1255409132
Payments from drug & device makers
Across 149 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$804
- Alkermes, Inc.$308
- AbbVie$282
- Teva Pharmaceuticals USA, Inc.$215
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
- Otsuka America Pharmaceutical, Inc.$130
- plus $472 from 8 others
What the payments were for
- Food & beverage$2,421100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,421 in reported general payments places this provider in the 80th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 24 | $182,210 |
| AustedoDeutetrabenazine | 24 | $122,467 |
| LybalviOlanzapine/Samidorphan Malate | 18 | $31,405 |
| TrintellixVortioxetine Hydrobromide | 14 | $13,669 |
| Aripiprazole | 41 | $6,015 |
| Bupropion XlBupropion Hcl | 84 | $3,514 |
| Oxcarbazepine | 65 | $2,929 |
| Quetiapine Fumarate | 109 | $2,379 |
| Vilazodone Hcl | 18 | $1,994 |
| Olanzapine | 62 | $1,563 |
| Duloxetine Hcl | 69 | $1,377 |
| Hydroxyzine Hcl | 84 | $1,200 |
| Bupropion Hcl SrBupropion Hcl | 81 | $1,176 |
| Gabapentin | 76 | $1,093 |
| Fluoxetine Hcl | 92 | $1,077 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $804 | $182,21024 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $215 | $122,46724 claims |
| Alkermes, Inc.Lybalvi | $308 | $31,40518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Rock Hill
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Cerrissa HugieCharleston$54K
- Karen FulwoodMyrtle Beach$30K
- Taylor CrewsIsle Of Palms$28K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- Mary McManusNorth Myrtle Beach$15K
- Kelsie FowlerAnderson$15K
- William HendricksGreenville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.